Current and Future Landscape of Innovative Technologies for Respiratory Function Analysis: Decentralized Clinical Trials Perspective

Register Free: http://www.appliedclinicaltrialsonline.com/act_w/innovative_tech

Event Overview:

IQVIA leaders Dr. Tapan K. Raval and Mike Bruhns will discuss current and future use of wearables, sensors, and other medical devices to evaluate respiratory function within decentralized clinical trials (DCT) keeping the patient at the core. Novel devices of interest in this area use Forced Oscillation Technique (FOT) and sensors to record and evaluate lung acoustics and ventilation patterns.

This webinar will focus on the selection of best fit technology, enablers to increase compliance, ease of use of devices, and global logistics. Participants will gain an understanding of the nuances around the use of these devices within their decentralized clinical trials and equip them with the information they need for optimal decision making.

Key Learning:

• Understand the current and future landscape of innovative technologies for respiratory function analysis.
• How to formulate a strategy for using next generation devices to meet protocol objective and ensure regulatory compliance.
• Navigating the challenges of global device logistics to ensure study timeline are met and to mitigate risk.

Speakers Name and Title:

Speaker's Name: Dr. Tapan K. Raval

Speaker's Title: Director, Medical Devices Science & Technology, Strategic Solutions, Connected Devices, DSSM

Speaker's Name: Mike Bruhns

Speaker's Title: Director, Device Strategy, Vendor Partnerships and Logistic

Times and Date:

Tue, Nov 8, 2022 11:00 AM EST

Sponsor:

IQVIA

Register Free: http://www.appliedclinicaltrialsonline.com/act_w/innovative_tech